title: Arterial complications after living-related liver transplantation: single-center experience from West China.
abstract: Vascular complications after liver transplantation remain a major source of morbidity and mortality for recipients. In particular, patients receiving living-related liver transplantation (LRLT) experience a higher rate of vascular complications owing to the complex vascular reconstruction. Between July 2001 and December 2005, LRLTs were performed in our center on 33 patients with end-stage liver diseases. The 23 men and 10 women had a mean age of 32.6 +/- 11.3 years (range = 5 to 58 years). Of the 33 patients, the percentage of vascular complications was 9.09% (3 cases), including hepatic arterial thrombosis (HAT), hepatic arterial stenosis (HAS), or hepatic artery pseudoaneurysm (HAP) in one patient, respectively. No portal vein or hepatic vein complication occurred in our patients. Thrombectomy was performed in the patient with thrombosis. The patient with stenosis was treated with balloon angioplasty and endoluminal stent placement. The pseudoaneurysm was also successfully embolized to restore the blood flow toward the donor liver. Mean follow-up for all patients after LRLT was 18.0 +/- 5.4 months. The overall postoperative 30-day mortality rate was 6.06% (2/33). The 1-year survival rate was 86.36% in 22 patients with benign diseases and 72.73% in 11 patients with malignant diseases. However, no death was associated with vascular complications. Careful preoperative evaluation and intraoperative microsurgical technique for hepatic artery reconstructions are the keys to prevent vascular complications following LRLT. Immediate surgical intervention is required for acute vascular complications, whereas late complications may be treated by balloon angioplasty and endoluminal stent placement. Embolization may be a safe and effective approach in the treatment of a pseudoaneurysm of the hepatic artery.
authors.affiliation: Center of Liver Transplantation, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
authors.forename: X-Z
authors.initials: XZ
authors.lastname: Jiang
authors.forename: L-N
authors.initials: LN
authors.lastname: Yan
authors.forename: B
authors.initials: B
authors.lastname: Li
authors.forename: J-C
authors.initials: JC
authors.lastname: Zhao
authors.forename: W-T
authors.initials: WT
authors.lastname: Wang
authors.forename: F-G
authors.initials: FG
authors.lastname: Li
authors.forename: T-F
authors.initials: TF
authors.lastname: Wen
authors.forename: Y-K
authors.initials: YK
authors.lastname: Ma
authors.forename: Y
authors.initials: Y
authors.lastname: Zeng
authors.forename: M-Q
authors.initials: MQ
authors.lastname: Xu
authors.forename: J-Y
authors.initials: JY
authors.lastname: Yang
authors.forename: Z-H
authors.initials: ZH
authors.lastname: Li
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D006085:Graft Survival; D006498:Hepatectomy / Q000009:adverse effects*; D006801:Humans; D008107:Liver Diseases / Q000145:classification / Q000601:surgery; D017093:Liver Failure / Q000601:surgery*; D016031:Liver Transplantation / Q000401:mortality / Q000502:physiology*; D019520:Living Donors / Q000706:statistics & numerical data*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D015996:Survival Rate; D020858:Tissue and Organ Harvesting / Q000009:adverse effects*; D014652:Vascular Diseases / Q000453:epidemiology*